The International Conference on Viral Hepatitis and Liver Disease will be held in Shanghai in June 2012

The 14th International Conference on Viral Hepatitis and Liver Diseases (ISVHLD) will be held in Shanghai from June 22nd to 25th, 2012. This is the first time in 40 years since the establishment of the association that it has been held in a developing country.

The 14th International Conference on Viral Hepatitis and Liver Disease with the theme of "New Progress, New Challenges, and New Solutions" was jointly sponsored by the Chinese Academy of Engineering and the Shanghai Municipal People's Government. It is expected that 3,000 people will attend the conference. This is what the reporter learned from the press conference held in Beijing on the 7th.

At that time, some world-leading research results will be published at the conference. The world-famous experts in the field of liver diseases will comprehensively expound and discuss the progress of liver disease in scientific research, clinical and administrative aspects in recent years, and the difficulties faced and the future direction of development.

"This conference has three major features. First, it summarizes the progress of scientists in the field of liver disease in the world in recent years. Second, it shows that under the impetus of major infectious diseases, China obtained during the "Eleventh Five-Year Plan" period in the field of liver disease prevention and control. Progress; The third is to open up to developing countries, and even fight for funding, invites less developed countries to participate in the young scientists who have made achievements in the field of liver disease.” Wen Yumei, chairman of the Chinese Academy of Engineering, said.

"ISVHLD is the first and most important conference in the field of liver diseases in the world. Chinese researchers have made outstanding achievements in the prevention and control of liver diseases, especially in basic research," said Robert Tim, a representative of the International Consultative Committee.

ISVHLD has been held every three years since it was established in 1972. At the 13th ISVHLD held in 2009, an international advisory committee composed of world-famous experts voted to hold the 14th ISVHLD in Shanghai, China, and was chaired by Academician Wen Yumei.

GW501516 Capsule Liquid

MK-677 Ibutamoren Description :

1. Ibutamoren (MK-677,) acts as a potent, orally active hormone secretagogue, mimicking the stimulating action of the endogenous hormone ghrelin.

2. It has been demonstrated to increase the release of, and produces sustained increases in plasma levels of several hormones including hormone and , but without affecting cortisol levels.

3. MK-677 is currently under development as a potential treatment for reduced levels of these hormones which make it a promising therapy for the treatment of frailty in the elderly.

4. MK-677 also alters metabolism of body fat and so may have application in the treatment of obesity

Product name MK-677
Chemical name Ibutamoren
Category SARM
CAS 159752-10-0
M.W 624.77
MF C27H36N4O5S
Half life 24 hours
Storage at 20ºC 2 years



Our company offers variety of products which can meet your multifarious demands.including API Powder.Pharmaceutical Intermediates.Vitamins Powder.Plant Extracts.Food Additive.Peptide Powder and so on We adhere to the management principles of "quality first, customer first and credit-based" since the establishment of the company and always do our best to satisfy potential needs of our customers. Our company is sincerely willing to cooperate with enterprises from all over the world in order to realize a win-win situation since the trend of economic globalization has developed with anirresistible force.



product Photo:

mk677 powder

Shaanxi YXchuang Biotechnology Co., Ltd , https://www.peptidenootropic.com